Immuno Oncology Talks Sanofi

In the current episode of “Immuno Oncology Talks”, we discuss the clinical challenges and future perspectives of CAR-T cells with our experts, from the Oslo University Hospital in Norway, Dr Else Marit Inderberg and Dr Sébastien Wälchli. Dr Inderberg is the head of the immunomonitoring at the hospital and has a research focus on novel immunotherapies, and Dr Wälchli is leading the CAR development platform. MAT-BE-2400334 (ver.1.0) 04 2024

In our tenth episode of the “Immuno Oncology Talks”,  we will discuss oncogenes in relation to immune responses with our guest, Professor Juha Klefström, from the Finnish Cancer Institute at the University of Helsinki, Finland. Professor Klefström is an expert in breast cancer biology and immuno-oncology, leading a research group focusing on oncogenes like Myc, in relation to the immune system and the tumour immune micro environment.  MAT-BE-2400162 (ver.1 ) 02 2024 

In our ninth episode of the “Immuno Oncology Talks”, we will discuss the rapidly evolving field of the microbiome in cancer immunotherapy with our guest, Professor Jeroen Raes, from the Department of Microbiology, Immunology and Transplantation, KU Leuven, Belgium. Professor Raes has established a world leading lab, where they combine large-scale, next-generation sequencing with novel computational approaches to investigate the function and variability of the healthy human microbiome, and to ...

In our eight episode of the “Immuno Oncology Talks”, we will hear about the current challenges of getting cancer cell and gene therapies on the market from a health economic perspective. Our guest, Professor Cornelis Boersma, from University Medical Center Groningen and Open University, in the Netherlands, has an extensive experience within health economics and health care policy. Apart from his previous experience within the pharma industry, he is actively involved as a scientist, consultant...

This episode, the seventh of our “Immuno Oncology Talks”, will be covering “Therapeutic RNA vaccines in cancer immunotherapy”, with our two guests, Professor Karine Breckpot and Professor Kris Thielemans, from the Laboratory of Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, in Belgium. Both experts have a long background within innovative immunotherapy strategies in cancer, and especially within mRNA vaccination. Professor Thielemans and his tea...

In our sixth episode of “Immuno Oncology Talks”, we will discuss non-viral RNA treatment approaches in cancer immunotherapy with our guest, professor Karine Breckpot from the Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, in Belgium. Professor Breckpot has a strong background within innovative immunotherapy strategies in cancer, and especially with mRNA technologies as a way to target the immune system. MAT-BE-2300154 (ver.1.0) 0...